Study guide

3.3 Respiratory Mechanics, Gas Exchange, Gas Transport, Control of Breathing & Extreme Environments

Philippine Physician Licensure Examination Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: PLE Structure, Eligibility & Study Strategy

1.1 PLE Format, 2026 Schedule & the Statutory Passing Rule 1.2 Eligibility, Internship, PRC Filing & Test-Day Rules 1.3 Reading the 2025 Tables of Specifications & Building a Study Plan

2 Chapter 2: Physiology I: Cells, Blood, Nerve & Muscle

2.1 Homeostasis, Cell Function, Membrane Transport & Resting Potential 2.2 Blood Cells, Immunity, Hemostasis, Fibrinolysis & Blood Distribution 2.3 Action Potentials, Conduction, the Neuromuscular Junction & Muscle Contraction

3 Chapter 3: Physiology II: Cardiovascular & Respiratory Systems

3.1 Cardiac Electrophysiology, the Cardiac Cycle & the Heart as a Pump 3.2 Circulation: Resistance, Venous Return, Coronary Flow, Microcirculation & Fetal Circulation 3.3 Respiratory Mechanics, Gas Exchange, Gas Transport, Control of Breathing & Extreme Environments

4 Chapter 4: Physiology III: Gastrointestinal, Endocrine, Renal & Reproductive Systems

4.1 Gastrointestinal Physiology: Secretion, Motility, Digestion & Absorption 4.2 Endocrine Physiology: Hormone Chemistry, Axes, Calcium & Fuel Regulation 4.3 Renal Physiology, Body Fluid Balance & Acid-Base Regulation 4.4 Reproductive Physiology: Sexual Differentiation, Spermatogenesis, the Menstrual Cycle, Parturition & Lactation

5 Chapter 5: Physiology IV: Neurophysiology & Special Senses

5.1 Sensory Receptors, Somatic Sensation, Spinal Reflexes & Motor Control 5.2 Higher Brain Functions, Sleep, the Autonomic Nervous System, Cerebral Blood Flow & the Special Senses

6 Chapter 6: Legal Medicine I: Medicolegal Examination, Identification & Death

6.1 The Medicolegal Examination, Physical Evidence & the Crime Scene 6.2 Identification of the Living, the Dead & Skeletal Remains 6.3 Thanatology: Death, Brain Death, Postmortem Changes & Time of Death

7 Chapter 7: Legal Medicine II: Injuries, Sexual Crimes, Reproduction, Mental State & Poisoning

7.1 Physical Injuries: Revised Penal Code Classes, Wounds, Gunshot Injuries, Asphyxia & Burns 7.2 Sexual Crimes, Violence Against Women & Child Abuse 7.3 Medicolegal Aspects of Pregnancy, Delivery, Abortion, Infanticide, Paternity & Marriage 7.4 Disturbance of Mentality: Insanity, Intoxication, Capacity & the Mental Health Act 7.5 Forensic Toxicology & Poisoning: Diagnosis, Evidence, Antidotes & Philippine Laws

8 Chapter 8: Legal Medicine III: Reports, Regulation, Liability & Ethics

8.1 The Medicolegal Report, the Death Certificate, Autopsy Rules & Communicating with Relatives 8.2 Licensure & Regulation of Medical Practice: RA 2382, the Board of Medicine, PRC & Prescribing Laws 8.3 Medical Malpractice: Civil, Criminal & Administrative Liability and Key Philippine Doctrines 8.4 Physician Relationships Under the PMA Code of Ethics: Patients, Colleagues, Allied Health, Students, Industry, HMOs, Hospitals & PhilHealth 8.5 Bioethical Principles, Informed Consent, Confidentiality, End-of-Life & Research Ethics

9 Chapter 9: Pathology I: Cell Injury, Inflammation & Hemodynamics

9.1 Cell Injury, Adaptation, Necrosis, Apoptosis, Accumulations & Calcification 9.2 Acute & Chronic Inflammation, Granulomas, Systemic Effects & Tissue Repair 9.3 Hemodynamic Disorders: Edema, Hemorrhage, Thrombosis, Embolism, Infarction, DIC & Shock

10 Chapter 10: Pathology II: Genetics, Neoplasia, Immunity, Environment & Infection

10.1 Genetic Disorders & Neoplasia: Mendelian, Chromosomal, Non-Classic Inheritance, Tumor Biology & Markers 10.2 Immunopathology: Hypersensitivity, Autoimmunity, Immunodeficiency & Transplant Rejection 10.3 Environmental & Nutritional Pathology: Air Pollution, Tobacco, Metals, Occupational Lung Disease & Deficiency States 10.4 Pathology of Infectious Diseases: Transmission, Tissue Reaction Patterns & Diagnostic Morphology

11 Chapter 11: Pathology III: Gastrointestinal, Cardiovascular & Respiratory Pathology

11.1 Gastrointestinal, Hepatic, Biliary & Pancreatic Pathology 11.2 Cardiovascular & Collagen Pathology: Heart Failure, Congenital, Ischemic, Hypertensive, Valvular, Pericardial & Myocardial Disease 11.3 Respiratory Pathology: Atelectasis, Edema, ARDS, Obstructive & Restrictive Disease, Vascular Disease, Infections, Tumors & Pleura

12 Chapter 12: Pathology IV: Hematopoietic, Genitourinary, Endocrine & Nervous System Pathology

12.1 Hematopoietic Pathology: Anemias, Polycythemia, Bleeding Disorders, DIC & Lymphoid and Myeloid Neoplasms 12.2 Genitourinary Pathology: Glomerular, Tubulointerstitial, Vascular & Cystic Kidney Disease, Renal Tumors, Obstruction & Genital Disorders 12.3 Endocrine Pathology: Pancreas, Adrenal, Parathyroid, Thyroid & Pituitary Disorders 12.4 Nervous System Pathology: Cerebrovascular Disease, Edema & Herniation, Infections, Degenerative & Demyelinating Disease, Tumors

13 Chapter 13: Biochemistry I: Carbohydrate, Protein, Genetic & Energy Biochemistry

13.1 Carbohydrate Chemistry, Digestion, Glycolysis, Pyruvate Dehydrogenase & the Pentose Phosphate Pathway 13.2 Gluconeogenesis, Glycogen, Lipogenesis, Ketogenesis & Hormonal Control of Fuel Metabolism 13.3 Protein Digestion, Amino Acid Catabolism, the Urea Cycle, Heme Synthesis, Porphyrias & Bilirubin Metabolism 13.4 Amino Acids & Proteins: Structure, Properties, Separation, Specialized Products, Collagen & Protein Misfolding in Alzheimer Disease 13.5 Molecular Genetics & Enzymes: Replication, Repair, Gene Expression, Molecular Techniques, Lysosomal Storage Diseases & Enzyme Kinetics 13.6 Bioenergetics, the Citric Acid Cycle, Oxidative Phosphorylation, Muscle Energetics & Nucleotide Metabolism

14 Chapter 14: Biochemistry II: Respiratory, Nutritional, Immunologic & Cardiovascular Biochemistry

14.1 Respiratory Biochemistry: Hemoglobin, Oxygen Binding, Hemoglobinopathies, Thalassemias, Methemoglobin, Buffers & Acid-Base Balance 14.2 Nutrition Biochemistry: Dietary Standards (RENI to PDRI 2015), Food Guides, Protein Quality, Energy Expenditure, Breast Milk, Vitamins, Minerals & Blood Components 14.3 Immunology: Innate & Adaptive Immunity, the Immune Response, Antibodies, Complement, Cytokines & MHC 14.4 Cardiovascular Biochemistry: Cholesterol, Lipoproteins, Dyslipidemias, Atherogenesis, Myocardial Energetics, Biomarkers & Heart Failure

15 Chapter 15: Anatomy I: Thorax, Abdomen, Pelvis & Back

15.1 Thorax: Thoracic Wall, Breast, Pleura & Lungs, Mediastinum, Heart & Great Vessels 15.2 Abdomen: Abdominal Wall & Inguinal Region, Peritoneum, Viscera, Diaphragm & Posterior Abdominal Wall 15.3 Pelvis & Perineum: Bony Pelvis, Pelvic Floor, Pelvic Viscera, Vessels & Nerves, Perineal Pouches & the Anal Canal 15.4 Back & Spinal Column: Vertebrae, Curvatures, Joints, Back Muscles, Spinal Cord, Meninges & Cord Syndromes

16 Chapter 16: Anatomy II: Upper Limb, Lower Limb & Skin

16.1 Upper Limb: Bones, Superficial Veins, Shoulder Muscles, Axilla & Brachial Plexus, Arm, Cubital Fossa, Forearm, Hand & Joints 16.2 Lower Limb: Bones, Venous & Lymphatic Drainage, Thigh, Gluteal Region, Popliteal Fossa, Leg Compartments, Foot, Joints & Gait 16.3 Skin & Appendages: Epidermis, Junctions, Dermis, Subcutaneous Tissue, Fascia, Nerves, Vessels, Lymphatics, Hair, Nails & Glands

17 Chapter 17: Anatomy III: Head, Neck & Histology

17.1 Head I: Skull & Cranial Foramina, Scalp, Face & Parotid, Orbit, Temporal & Infratemporal Fossae, TMJ, Oral Region, Nose & Ear 17.2 Head II: Meninges & Dural Venous Sinuses, Brain Regions & Ventricles, Blood Supply, Cranial Nerves, Pituitary & Pineal, Brainstem Syndromes 17.3 Neck: Cervical Vertebrae & Hyoid, Fascial Layers, Superficial Muscles, Triangles, Root of the Neck, Visceral Layers & Lymphatics 17.4 Histology: Cells, Epithelium & Glands, Connective Tissue & Fat, Cartilage & Bone, Blood & Hematopoiesis, Muscle, Nerve, Vessels, Lymphoid Organs & Organ Histology

18 Chapter 18: Microbiology I: Foundations, Respiratory & Cardiovascular Infections

18.1 Microbiology Foundations: The Organ-System TOS, Specimens & Stains, Gram-Positive and Gram-Negative Bacteria 18.2 Respiratory Infections: Tonsillitis, Sinusitis & Mastoiditis, Bronchitis, Community-Acquired & Severe Pneumonia, Bronchiectasis and Paragonimiasis 18.3 Tuberculosis, Leprosy & Nontuberculous Mycobacteria: Pathogenesis, Diagnosis, NTP Regimens & Prevention 18.4 Cardiovascular Infections: Infective Endocarditis, Rheumatic Fever & Rheumatic Heart Disease, Myocarditis, Pericarditis and Septic Thrombophlebitis

19 Chapter 19: Microbiology II: Gastrointestinal & Nervous System Infections

19.1 Gastrointestinal Infections I: Gastroenteritis & Enterocolitis, Cholera, Typhoid & Salmonellosis, Shigellosis, Food Poisoning and Viral Hepatitis 19.2 Gastrointestinal Infections II: Amebiasis, Giardiasis & Cryptosporidiosis, Soil-Transmitted Helminths, Pinworm, Capillariasis and Tapeworms 19.3 Nervous System Infections: Meningitis & CSF Patterns, Encephalitis, Rabies and DOH PEP, Spinal Cord Infections, Tetanus & Botulism, Paralytic Shellfish Poisoning

20 Chapter 20: Microbiology III: Genitourinary, Reproductive, Blood & Skin Infections

20.1 Genitourinary Infections: Cystitis & Pyelonephritis, Urine Diagnostics, Urethritis, Balanoposthitis, Pelvic Inflammatory Disease and Genital Ulcers 20.2 Reproductive Tract Infections & STIs: Syphilis, Genital & Neonatal Herpes, HPV, Molluscum, CMV, Trichomoniasis & Vaginitis, Cervicitis, Prostatitis and Orchitis 20.3 Hematopoietic & Lymphatic Infections: Dengue and Other Hemorrhagic Fevers, Malaria, Lymphatic Filariasis, Lymphogranuloma Venereum and Epstein-Barr Virus 20.4 Integumentary Infections: Viral Exanthems (Measles, Mumps, Rubella, Varicella, Smallpox & Mpox, Fifth Disease), Herpesviruses, Fungal Skin Infections and Tick-Borne Diseases

21 Chapter 21: Microbiology IV: Musculoskeletal & Multisystemic Infections

21.1 Musculoskeletal & Soft-Tissue Infections: Osteomyelitis, Septic & Reactive Arthritis, Pyomyositis & Gas Gangrene, Cellulitis, Necrotizing Fasciitis and Bite Wounds 21.2 Multisystemic Infections I: Septicemia, Septicopyemia & Septic Shock, Leptospirosis and Schistosomiasis japonica 21.3 Multisystemic Infections II: HIV/AIDS Virology, the Philippine Epidemic & RA 11166, Diagnosis (rHIVda), ART, Prevention and Opportunistic Infections including Toxoplasmosis

22 Chapter 22: Obstetrics I: Prenatal Care, Labor & Obstetric Bleeding

22.1 Prenatal Care: Diagnosis of Pregnancy, Maternal Physiology, Dating, Nutrition & Supplements, Screening Tests and the DOH Antenatal Package 22.2 Labor & Parturition: Signs of Labor, Pelvis and Passenger, Stages and Cardinal Movements, Partograph, Fetal Monitoring, Dystocia, Shoulder Dystocia, Operative Delivery, Preterm Labor, PROM and Adolescent Pregnancy 22.3 Early Pregnancy Risks & Bleeding: Hyperemesis, Spontaneous Abortion, Recurrent Loss & Cervical Insufficiency, Ectopic Pregnancy, Hydatidiform Mole & Gestational Trophoblastic Neoplasia 22.4 Hemorrhagic Complications of Pregnancy: Placenta Previa, Abruption, Vasa Previa, Placenta Accreta Spectrum, Uterine Rupture, Third-Stage Management and Postpartum Hemorrhage

23 Chapter 23: Obstetrics II: Fetal, Hypertensive, Medical, Infectious & Postpartum Problems

23.1 Fetal Complications: Malpresentation & Breech, Macrosomia, Fetal Growth Restriction, Amniotic Fluid Disorders, Antepartum Surveillance, Rh Alloimmunization, Multiple Gestation and Post-Term Pregnancy 23.2 Hypertension & Diabetes in Pregnancy: Classification, Preeclampsia Pathogenesis and Prevention, Severe Features, Eclampsia & HELLP, Magnesium Sulfate, Gestational and Pregestational Diabetes 23.3 Medical & Surgical Disorders in Pregnancy: Drug Pharmacokinetics, Epilepsy, Thyroid, Heart Disease, SLE & APS, Asthma, Liver Disorders, Anemia, Dermatoses, Appendicitis, Gallstones, Stones and Trauma 23.4 Perinatal Infections: Triple Elimination (HIV, Syphilis, Hepatitis B), Group B Streptococcus, Chorioamnionitis, Gonorrhea & Chlamydia, Condyloma, Herpes and the TORCH Infections 23.5 Postpartum Care & Complications: Normal Puerperium, Postnatal Visits, Breastfeeding, Puerperal Fever and Infection, Mastitis, Late Hemorrhage, Mood Disorders, VTE and Postpartum Contraception

24 Chapter 24: Gynecology I: Benign Disorders, Infections & Contraception

24.1 Benign Lower Genital Tract Disorders & Pelvic Floor: Vulvar Dermatoses, Bartholin Cysts, Vaginal and Cervical Lesions, Premalignant Lesions, Pelvic Organ Prolapse, Urinary Incontinence and Fistula 24.2 Benign Upper Genital Tract Disorders: Leiomyoma, Adenomyosis & Endometriosis, Endometrial Polyps and Hyperplasia, Functional Cysts and Benign Ovarian Tumors, Adnexal Torsion and Tubal Disease 24.3 Infections of the Female Reproductive Tract: Burden & Screening, Syndromic Management, Vaginitis and Cervicitis, Pelvic Inflammatory Disease & Tubo-Ovarian Abscess, Genital Tuberculosis and Toxic Shock 24.4 Contraception & Family Planning: The RH Law, Effectiveness, Natural and Barrier Methods, Hormonal Methods, IUDs, Permanent Methods, Emergency Contraception and the WHO Eligibility Criteria

25 Chapter 25: Gynecology II: Reproductive Endocrinology, Oncology & Special Issues

25.1 Reproductive Endocrinology & Menstrual Disorders: The Menstrual Cycle, Puberty, Abnormal Uterine Bleeding (PALM-COEIN), Amenorrhea, PCOS, Hyperprolactinemia, Dysmenorrhea, Infertility, Menopause, HRT and Osteoporosis 25.2 Gynecologic Oncology: Cervical Cancer Screening, Staging & Treatment, Endometrial Cancer and Lynch Syndrome, Ovarian Tumors and BRCA, Vulvar and Vaginal Cancer, Survival and Quality of Life 25.3 Contemporary Issues & Pediatric and Adolescent Gynecology: Violence Against Women, Sexual Assault Care, Breast Disorders, Ethics of Maternal-Fetal Conflict, and Gynecologic Problems of Children and Adolescents

26 Chapter 26: Pediatrics I: Newborn, Growth, Nutrition, Immunization & Infections

26.1 The Newborn: Normal Findings and Variants, EINC (Unang Yakap), APGAR, Neonatal Resuscitation, Routine Care & Newborn Screening, Jaundice, Respiratory Distress, Hypoglycemia and Neonatal Sepsis 26.2 Growth, Development & Nutrition: Growth Parameters, Milestones and Red Flags, Speech Delay, Autism, ADHD & Global Delay, Breastfeeding and Feeding, Micronutrient Deficiencies, Malnutrition and Obesity 26.3 Immunization: RA 10152 and the National Immunization Program Schedule, Fully Immunized Child, School-Based Immunization, Other Recommended Vaccines, Vaccine Types, Cold Chain, Contraindications and AEFI 26.4 Pediatric Infectious Diseases: Bacterial (Diphtheria to Congenital Syphilis), Childhood TB, Viral Exanthems and Infections, Dengue in Children, Pediatric HIV, Protozoal, Helminthic and Fungal Infections

27 Chapter 27: Pediatrics II: Respiratory, Cardiovascular, Neurologic & Gastrointestinal Disorders

27.1 Pediatric Respiratory Disorders: IMCI Danger Signs and Cough Assessment, URI, Tonsillitis & Peritonsillar Abscess, Croup, Epiglottitis, Foreign Body, Bronchiolitis, Pneumonia, Pleural Effusion and Complications 27.2 Pediatric Cardiovascular & Collagen Disorders: Heart Sounds and Murmurs, Acyanotic and Cyanotic Congenital Heart Disease, Eisenmenger, Hypercyanotic Spells, Heart Failure, Rheumatic Fever, Hypertension, Endocarditis, Kawasaki, SLE, JIA, Dermatomyositis and Pediatric Resuscitation 27.3 Pediatric CNS Disorders: Febrile Seizures, Epilepsy Syndromes, Status Epilepticus, Meningitis and Encephalitis in Children, Cerebral Palsy, Hydrocephalus & Neural Tube Defects, Headache and Migraine, and Brain Tumors 27.4 Pediatric GI Disorders & Poisoning: Vomiting (Pyloric Stenosis, Atresias, Malrotation, Intussusception, GERD), Diarrhea and IMCI Rehydration Plans, Abdominal Pain, Constipation & Hirschsprung, Jaundice, Biliary Atresia & Choledochal Cyst, Hepatitis, Food Allergy, and Kerosene, Aspirin and INH Poisoning

28 Chapter 28: Pediatrics III: Genitourinary, Endocrine, Hematologic & Oncologic Disorders

28.1 Pediatric Genitourinary Disorders & Child Abuse: UTI and Vesicoureteral Reflux, Post-Streptococcal GN and Other Nephritides, Nephrotic Syndrome, AKI and HUS, CKD, Congenital Urogenital Anomalies, and Recognizing and Reporting Child Abuse 28.2 Pediatric Endocrine & Metabolic Disorders: Short Stature and Growth Hormone, Gigantism, Diabetes Insipidus, Congenital Hypothyroidism, Graves Disease & Goiter, Type 1 Diabetes and DKA, Congenital Adrenal Hyperplasia, Cushing Syndrome, Pheochromocytoma and Adrenal Crisis 28.3 Pediatric Hematology, Allergy & Immunology: Normal Hemogram and Immunoglobulins by Age, Anemias (Iron Deficiency, Thalassemia, G6PD, Spherocytosis, Aplastic), Bleeding Disorders (ITP, Hemophilia, vWD, DIC, Vitamin K), IgA Vasculitis, Rashes and Drug Reactions, Asthma, Allergic Rhinitis and Primary Immunodeficiencies 28.4 Pediatric Oncology & Genetics: Leukemias and Lymphomas, Retinoblastoma, Wilms Tumor, Neuroblastoma, Ewing Sarcoma and Osteosarcoma; Sex Chromosome and Autosomal Disorders, Inborn Errors of Metabolism and the Dysmorphic ("Odd-Looking") Child

29 Chapter 29: Preventive Medicine I: The Physician as Health Care Provider

29.1 The Physician as Health Care Provider I: Natural History of Disease, Disease Causation, Levels of Prevention and Primary Care Across the Clinical Rotations 29.2 The Physician as Health Care Provider II: The Filipino Family and Family Assessment Tools, Health Education and Promotion, Behavior Change Models and Geriatric Medicine 29.3 The Physician as Health Care Provider III: The Primary Health Care Concept (Alma-Ata, Astana, Philippine PHC) and Mental Health in Primary Care under RA 11036

30 Chapter 30: Preventive Medicine II: Philippine Health Care System & Community Medicine

30.1 The Philippine Health Care System: DOH Structure, Levels of Care and Referral, Devolution under RA 7160, the Universal Health Care Act (RA 11223), PhilHealth and YAKAP, and Leading Causes of Morbidity and Mortality 30.2 Epidemiology, Surveillance & Outbreaks: Measures of Disease Occurrence and Association, Rates, Endemic and Epidemic Levels, PIDSR and RA 11332 Notifiable Diseases, the Ten Steps of Outbreak Investigation and Epidemic Curves 30.3 DOH Programs & Environmental Sanitation: TB, Dengue, Rabies, Leprosy, Helminth and Other Disease Programs; the Sanitation Code (PD 856), Water Supply and Potability, Excreta and Solid Waste, Food Sanitation and Health Care Waste 30.4 Community Medicine: Principles of Public Health Administration and Program Planning, Vital Health Indices (Infant and Maternal Mortality), the Ecologic Concept of Health, Lifestyle and Non-Communicable Diseases, Health-Seeking Behavior and Traditional Medicine

31 Chapter 31: Preventive Medicine III: Manager, Researcher & Social Mobilizer

31.1 The Physician as Administrative Manager: Communication and Interpersonal Skills, Teamwork, Adult Learning, Occupational Health (RA 11058), Bioethics, Palliative Care, School Health, Organ Transplantation and Birth and Death Certificates 31.2 The Physician as Researcher I: The Research Process and Proposal, Research Ethics, Study Designs and Meta-Analysis, Demography and Vital Statistics, Evidence-Based Medicine and Quality Assurance 31.3 The Physician as Researcher II: Biostatistics (Data Types, Distributions, Central Tendency and Dispersion, Confidence Intervals, Hypothesis Testing and Test Selection) and Screening Tests (Validity, Predictive Values, Likelihood Ratios, Biases and Program Criteria) 31.4 The Physician as Social Mobilizer and Leader: Philippine Health Laws, Decrees and Executive Orders, Principles of Social Mobilization and Community Organizing, and Disaster Risk Reduction and Management in Health

32 Chapter 32: Pharmacology I: Principles, Cardiovascular & Nervous System Therapeutics

32.1 Pharmacology Foundations: The Pharmacology TOS, Pharmacokinetics, Drug Metabolism and Interactions, Pharmacodynamics, Adverse Drug Reactions and Monitoring, Autonomic Pharmacology, and Philippine Prescribing Rules 32.2 Cardiovascular Pharmacology I: Cardiac Arrest and ACLS Drugs, Bradycardia and Complete Heart Block, Antiarrhythmics, Anticoagulation in Atrial Fibrillation, Antianginals, ACS Therapy and Fibrinolysis, Pericarditis and Endocarditis Regimens 32.3 Cardiovascular Pharmacology II: Antihypertensives and Diuretics, Hypertensive Emergencies, Vasopressors and Inotropes in Shock, Heart Failure GDMT and Digoxin, and Lipid-Lowering Therapy 32.4 Nervous System Pharmacology I: Antiseizure Drugs and Status Epilepticus, Headache and Migraine, Vertigo, Stroke Thrombolysis and Secondary Prevention, Encephalopathy, Dementia, ADHD, Parkinson Disease and Movement Disorders, Raised Intracranial Pressure and CNS Infections

33 Chapter 33: Pharmacology II: Psychiatric, Respiratory & Genitourinary Therapeutics

33.1 Nervous System Pharmacology II: Antidepressants and Their Toxicity, Serotonin Syndrome, Anxiolytics and Hypnotics, Antipsychotics, EPS and NMS, Lithium and Mood Stabilizers, Sleep Disorders, Agitation and Alcohol Withdrawal 33.2 Respiratory Pharmacology: Cough and Colds, Allergic Rhinitis, Asthma (Controllers, Relievers, Exacerbations), COPD, Anti-TB Drugs, Antibiotics for Pneumonia and Bronchitis, and Lung Cancer Therapy 33.3 Genitourinary Pharmacology I: Antimicrobial Classes and Toxicities, and Drug Treatment of UTI, Pyelonephritis, Gonorrhea, Chlamydia, Syphilis, Genital Herpes, Genital Warts, PID, Vaginitis, Prostatitis and Orchitis 33.4 Genitourinary Pharmacology II: Kidney Stones, Nephrotic and Nephritic Disease, Drug Dosing in Kidney Disease and Hyperkalemia, Benign Prostatic Hyperplasia, Erectile Dysfunction, Renal Cell Carcinoma and Prostate Cancer Therapy

34 Chapter 34: Pharmacology III: Digestive, Endocrine, Skin & Musculoskeletal Therapeutics

34.1 Digestive Pharmacology: Portal Hypertension and Variceal Bleeding, Acid-Peptic Disease, H. pylori and GERD, Antiemetics, Laxatives and Antidiarrheals, Biliary and Pancreatic Disease, GI Infections and Parasites, Viral Hepatitis, C. difficile, Candidiasis and GI Cancer Chemotherapy 34.2 Endocrine Pharmacology I: Diabetes Mellitus Drugs (Metformin, Sulfonylureas, SGLT2 Inhibitors, GLP-1 Agonists, DPP-4 Inhibitors, Thiazolidinediones, Insulins), Choosing Therapy by Comorbidity, DKA and HHS, and Hypoglycemia 34.3 Endocrine Pharmacology II: Pituitary Disorders (GH Deficiency, Acromegaly, Prolactinoma, Diabetes Insipidus, Panhypopituitarism), Thyroid Drugs and Thyroid Storm, Calcium and Parathyroid Disorders, Adrenal Disorders and Corticosteroids 34.4 Cutaneous and Musculoskeletal Pharmacology: Cellulitis and Abscess, Drug-Induced Skin Reactions (SJS/TEN), Pain Management (Paracetamol, NSAIDs, Opioids), Osteoporosis, Rheumatoid Arthritis and Osteoarthritis, Septic and TB Arthritis, Gout, SLE and Psoriasis

35 Chapter 35: Surgery I: Basic Surgical Principles

35.1 Basic Surgical Principles I: The Surgery TOS, Fluids and Electrolytes, Acid-Base Balance, the Metabolic Response to Injury, Surgical Nutrition and Blood Transfusion 35.2 Basic Surgical Principles II: Shock and Surgical Critical Care, Hemorrhagic Shock and Massive Transfusion, ATLS Primary and Secondary Survey, Chest and Abdominal Trauma, Head and Spine Injury, Pelvic Fractures and Burns 35.3 Basic Surgical Principles III: Preoperative Assessment, Wound Healing, Surgical Infection and Asepsis, Postoperative Fever, Surgical Oncology, Immunology and Transplantation, Anesthesia and Patient Safety

36 Chapter 36: Surgery II: Abdomen, Breast & Hernia

36.1 Abdomen I: Esophagus (Hiatal Hernia, GERD, Achalasia, Caustic Injury, Barrett, Boerhaave, Mallory-Weiss, Cancer), Stomach and Duodenum (Peptic Ulcer Complications, Upper GI Bleeding, Gastric Cancer, GIST), Small Bowel (Obstruction, Ileus, Tumors, Typhoid and TB), Retroperitoneum and Abdominal Wall 36.2 Abdomen II: Gallstones, Cholecystitis, Choledocholithiasis and Cholangitis, Obstructive Jaundice, Liver (Cirrhosis, Portal Hypertension, Abscesses, Tumors and Hepatocellular Carcinoma), Pancreas (Acute and Chronic Pancreatitis, Pancreatic Cancer) and Spleen (Splenectomy, OPSI) 36.3 Abdomen III: Acute Appendicitis, Colonic Obstruction and Volvulus, Lower GI Bleeding, Diverticular Disease, Colorectal Polyps and Cancer, Hemorrhoids, Anal Fissure, Perianal Abscess and Fistula 36.4 Breast, Hernia and Skin and Soft Tissue: Benign Breast Masses, Breast Cancer Evaluation and Treatment, Groin and Abdominal Wall Hernias, Benign Skin and Soft-Tissue Tumors, Skin Cancers and Soft-Tissue Sarcoma

37 Chapter 37: Surgery III: Surgical Specialties

37.1 Head and Neck, Thyroid, Parathyroid, Endocrine and Bariatric Surgery and Otorhinolaryngology: Neck Masses and Head and Neck Cancer, Salivary Glands, Thyroid Nodules and Cancer, Goiter and Hyperthyroidism Surgery, Hyperparathyroidism, Adrenal Surgery, Bariatric Surgery, Nasal Polyps, Epistaxis, Vertigo, Hearing Loss and ENT Infections 37.2 Specialty I: Neurosurgery (Raised Intracranial Pressure and Herniation, Head Injury and Hematomas, Spontaneous Intracranial Hemorrhage, CNS and Peripheral Nerve Tumors, Spinal Cord Compression, Neurosurgical Infections) and Ophthalmology (Glaucoma, Cataract, Ophthalmic Emergencies) 37.3 Specialty II: Thoracic and Cardiovascular Surgery (Pleural Effusion and Empyema, Lung Cancer, Mediastinal Masses, Surgical Heart Disease, Aortic Aneurysm and Dissection, Peripheral Arterial and Venous Disease), Urology (Stones, Infections, Torsion, BPH, Urologic Tumors) and Gynecologic Surgery 37.4 Specialty III: Plastic and Reconstructive Surgery (Skin Grafts and Flaps, Cleft Lip and Palate, Facial Fractures, Hand Injuries), Orthopedics (Fractures, Dislocations, Bone and Joint Infections, Bone Tumors) and Pediatric Surgery (Hernias, CDH, Esophageal Atresia, Obstruction, Hirschsprung Disease, Neonatal Jaundice, Tumors)

38 Chapter 38: Medicine I: Cardiovascular, Digestive & Endocrine Medicine

38.1 Cardiovascular Medicine I: Hypertension and Secondary Causes, Dyslipidemia, Stable Angina and Acute Coronary Syndromes, Post-MI Complications, Heart Failure and Shock Syndromes 38.2 Cardiovascular Medicine II: Tachyarrhythmias and Bradyarrhythmias, Atrial Fibrillation, Sudden Cardiac Death and Brugada Syndrome, Cardiac Arrest, Valvular and Rheumatic Heart Disease, Infective Endocarditis, Myocarditis and Pericardial Disease 38.3 Gastroenterology and Hepatology: GERD and Peptic Ulcer Disease, Upper and Lower GI Bleeding, Diarrhea and GI Infections, Acute Pancreatitis and Biliary Disease, Viral Hepatitis, Cirrhosis and Portal Hypertension, Liver and GI Cancers 38.4 Endocrinology: Diabetes Mellitus Diagnosis, Treatment and Complications, DKA and HHS, Thyroid Disease, Pituitary Disorders, Adrenal Disorders (Cushing, Aldosteronism, Addison, Pheochromocytoma), Calcium and Parathyroid Disorders, Obesity and Metabolic Syndrome

39 Chapter 39: Medicine II: Hematology, Systemic Infections, Renal & Respiratory Medicine

39.1 Hematology, Immunology and Systemic Infections: Anemias (Iron Deficiency, Thalassemia, G6PD Deficiency, Megaloblastic, Hemolytic), Acute and Chronic Leukemias and Their Emergencies, Allergic Disorders, Dengue in Adults, COVID-19, Malaria and HIV/AIDS Opportunistic Infections 39.2 Nephrology: Acute Kidney Injury, Chronic Kidney Disease and Dialysis, Sodium and Potassium Disorders, Acid-Base Analysis, Urinary Tract Infections, Glomerular Diseases (Nephritic and Nephrotic), Kidney Stones, Renal Tumors and Sexually Transmitted Infections 39.3 Pulmonology and Critical Care: Acute Respiratory Failure and Oxygen Therapy, Bronchial Asthma, COPD, Community- and Hospital-Acquired Pneumonia, Pulmonary Tuberculosis and TB Infection, Pulmonary Embolism, Lung Cancer and ARDS

40 Chapter 40: Medicine III: Rheumatology, Dermatology, Neurology, Rehabilitation & Psychiatry

40.1 Rheumatology and Dermatology: Approach to Arthritis, Osteoarthritis, Rheumatoid Arthritis, Gout, Spondyloarthritis, SLE and Other Connective Tissue Diseases, Vasculitis and Myalgias, Bone Tumors, Common Skin Lesions, Skin Infections and Infestations, Eczema, Psoriasis, Severe Drug Eruptions and Skin Signs of Systemic Disease 40.2 Neurology and Rehabilitation Medicine: Stroke and TIA (Localization, Thrombolysis, Thrombectomy, Secondary Prevention), Intracranial Hemorrhage, Seizures and Status Epilepticus, Meningitis and Encephalitis, Tetanus and Rabies, Parkinsonism, Neuromuscular and Degenerative Diseases, Dementia, CNS Tumors, Post-Stroke Rehabilitation and Musculoskeletal Disorders 40.3 Psychiatry: Mental Status Examination, Depressive Disorders, Bipolar Disorder, Schizophrenia and Other Psychoses, Anxiety Disorders, OCD and Trauma-Related Disorders, Substance Use, and Acute Psychiatric Emergencies (Suicide Risk, Agitation, Withdrawal, Wernicke Encephalopathy)

3.3 Respiratory Mechanics, Gas Exchange, Gas Transport, Control of Breathing & Extreme Environments

Key Takeaways Explain This Topic AI

FEV1/FVC below 0.70 with normal or high TLC means obstruction; reduced TLC (below 80% predicted) with a normal or high ratio means restriction.

The alveolar-arterial (A-a) gradient is normal in pure hypoventilation and at altitude, and widened in V/Q mismatch, shunt and diffusion impairment; shunt hypoxemia barely improves on 100% oxygen.

About 70% of CO2 travels as bicarbonate (carbonic anhydrase in red cells), about 20% to 23% as carbamino compounds and about 7% to 10% dissolved.

Central chemoreceptors respond to CO2 through the H+ of cerebrospinal fluid; peripheral (carotid body) chemoreceptors are the main sensors of arterial PO2 below about 60 mmHg.

At altitude, hypoxic hyperventilation causes respiratory alkalosis; in diving, Boyle's law explains barotrauma and rapid ascent causes decompression sickness from nitrogen bubbles.

Last updated: October 2026

Why this area matters

The respiratory TOS area lists:

  • mechanics of breathing;
  • pulmonary gas exchange and its disorders;
  • blood gas transport;
  • control of respiration;
  • acid-base balance;
  • the effects of exercise;

the effects of "extreme environment such as flying, place and diving".

These topics underpin asthma and COPD in Medicine, neonatal respiratory distress in Pediatrics, and ventilator and trauma care in Surgery.

  • Respiratory Mechanics, Lung Volumes & Compliance
  • Static Lung Volumes & Capacities

Tidal Volume ( V T ≈ 500 mL V_T \approx 500\text{ mL} V T ​ ≈ 500 mL ) : Normal volume inspired and expired at rest.

Inspiratory Reserve Volume ( I R V ≈ 3000 mL IRV \approx 3000\text{ mL} I R V ≈ 3000 mL ) : Maximal additional volume inspired after a normal tidal inspiration.

Expiratory Reserve Volume ( E R V ≈ 1100 mL ERV \approx 1100\text{ mL} ER V ≈ 1100 mL ) : Maximal additional volume exhaled after a normal tidal expiration.

Residual Volume ( R V ≈ 1200 mL RV \approx 1200\text{ mL} R V ≈ 1200 mL ) : Volume remaining in lungs after maximal forced expiration. Cannot be measured by simple spirometry ; requires helium dilution, nitrogen washout, or body plethysmography.

Vital Capacity ( V C = I R V + V T + E R V ≈ 4600 mL VC = IRV + V_T + ERV \approx 4600\text{ mL} V C = I R V + V T ​ + ER V ≈ 4600 mL ) .

Functional Residual Capacity ( F R C = E R V + R V ≈ 2300 mL FRC = ERV + RV \approx 2300\text{ mL} FRC = ER V + R V ≈ 2300 mL ) : Volume remaining in the lungs at the end of a passive tidal expiration. At FRC, the inward elastic recoil of the lungs precisely equals the outward elastic recoil of the chest wall , generating a resting subatmospheric intrapleural pressure of − 5 cm H 2 O -5\text{ cm H}_2\text{O} − 5 cm H 2 ​ O .

Total Lung Capacity ( T L C = V C + R V ≈ 5800 mL TLC = VC + RV \approx 5800\text{ mL} T L C = V C + R V ≈ 5800 mL ) .

Spirometry: Obstructive vs. Restrictive Patterns

Parameter Obstructive Lung Disease Restrictive Lung Disease

Primary Pathology Increased airway resistance and expiratory flow limitation Decreased lung parenchymal or chest wall compliance

  • F E V 1 FEV_1 FE V 1 ​ Markedly reduced ( < 80 % < 80\% < 80% predicted) Reduced proportionally with FVC
  • F V C FVC F V C Normal or moderately reduced Markedly reduced ( < 80 % < 80\% < 80% predicted)

F E V 1 / F V C FEV_1 / FVC FE V 1 ​ / F V C Ratio Reduced ( < 0.70 < 0.70 < 0.70 or < 70 % < 70\% < 70% ) (Diagnostic Hallmark) Normal or Elevated ( ≥ 0.70 \ge 0.70 ≥ 0.70 , often > 80 % > 80\% > 80% )

Total Lung Capacity ( T L C TLC T L C ) Normal or increased ( > 120 % > 120\% > 120% , hyperinflation) Reduced ( < 80 % < 80\% < 80% predicted) (Definitive Diagnosis)

Residual Volume ( R V RV R V ) Markedly increased (air trapping) Reduced

Examples COPD (emphysema, chronic bronchitis), asthma, bronchiectasis Idiopathic pulmonary fibrosis, sarcoidosis, scoliosis, ALS

Pulmonary Compliance, Surface Tension & Surfactant

Compliance ( C = Δ V / Δ P C = \Delta V / \Delta P C = Δ V /Δ P ) measures distensibility. According to the Law of Laplace for a spherical alveolus:

P = 2 T r P = \frac{2T}{r} P = r 2 T ​

Where P P P is the inward collapsing pressure, T T T is surface tension, and r r r is alveolar radius. Without surfactant, smaller alveoli ( r r r small) would generate higher collapsing pressures than adjacent larger alveoli, emptying their contents into larger alveoli and causing widespread atelectasis.

Pulmonary Surfactant : Synthesized and stored in lamellar bodies by Type II alveolar pneumocytes starting around 24 to 28 weeks of gestation. Composed primarily of dipalmitoylphosphatidylcholine (DPPC) and surfactant proteins (SP-A, B, C, D).

Mechanism : Surfactant molecules interlock at the air-water interface, reducing surface tension T T T proportionally more as alveolar surface area shrinks. This equalizes collapsing pressures across alveoli of differing radii, prevents alveolar collapse at end-expiration (atelectasis), increases lung compliance, and decreases the work of breathing.

Neonatal Respiratory Distress Syndrome (NRDS) : Occurs in premature infants with inadequate surfactant production (lecithin-sphingomyelin ratio < 2.0 < 2.0 < 2.0 in amniotic fluid). Presents with tachypnea, grunting, intercostal retractions, and diffuse "ground-glass" atelectasis on chest radiography. Managed with maternal antenatal corticosteroids (betamethasone) to accelerate Type II pneumocyte maturation, and exogenous intratracheal surfactant at birth.

  • Ventilation-Perfusion ( V / Q V/Q V / Q ) Matching & Oxygen-Hemoglobin Dissociation
  • Regional V / Q V/Q V / Q Ratios in the Upright Lung

Gravity exerts hydrostatic effects on both ventilation ( V V V ) and pulmonary blood flow ( Q Q Q ):

Apex (West Zone 1/2) : Both V V V and Q Q Q are lower than at the base, but blood flow is reduced far more drastically by hydrostatic pressure gradients. Consequently, the V / Q V/Q V / Q ratio is high ( ∼ 3.0 \sim 3.0 ∼ 3.0 ) , resulting in high alveolar P O 2 PO_2 P O 2 ​ ( 130 mmHg 130\text{ mmHg} 130 mmHg ) and low P C O 2 PCO_2 PC O 2 ​ ( 28 mmHg 28\text{ mmHg} 28 mmHg ). Mycobacterium tuberculosis preferentially infects lung apices due to high oxygen tension.

Base (West Zone 3) : Both V V V and Q Q Q are highest, but perfusion outstrips ventilation. The V / Q V/Q V / Q ratio is low ( ∼ 0.6 \sim 0.6 ∼ 0.6 ) , resulting in lower P O 2 PO_2 P O 2 ​ ( 89 mmHg 89\text{ mmHg} 89 mmHg ) and higher P C O 2 PCO_2 PC O 2 ​ ( 42 mmHg 42\text{ mmHg} 42 mmHg ). The global average resting lung V / Q V/Q V / Q is roughly 0.8 0.8 0.8 .

Pathological Extremes of V / Q V/Q V / Q

Right-to-Left Shunt ( V / Q = 0 V/Q = 0 V / Q = 0 ) : Perfusion without ventilation. Occurs in alveolar consolidation (lobar pneumonia), complete atelectasis, foreign body aspiration, and cyanotic congenital heart disease (Tetralogy of Fallot). Venous blood bypasses ventilated gas exchange surfaces. Clinical Hallmark : Severe hypoxemia that fails to correct significantly with 100 % 100\% 100% supplemental oxygen , because the administered gas cannot contact shunted blood.

Alveolar Dead Space ( V / Q = ∞ V/Q = \infty V / Q = ∞ ) : Ventilation without perfusion. Occurs in pulmonary embolism where an occlusive thromboembolus blocks downstream arterial flow. Dead space fraction is calculated using the Bohr-Enghoff Equation : V D V T = P a C O 2 − P E C O 2 P a C O 2 \frac{V_D}{V_T} = \frac{PaCO_2 - P_E CO_2}{PaCO_2} V T ​ V D ​ ​ = P a C O 2 ​ P a C O 2 ​ − P E ​ C O 2 ​ ​ Where P a C O 2 PaCO_2 P a C O 2 ​ is arterial P C O 2 PCO_2 PC O 2 ​ and P E C O 2 P_E CO_2 P E ​ C O 2 ​ is mixed expired P C O 2 PCO_2 PC O 2 ​ .

Hypoxic Pulmonary Vasoconstriction (HPV) : Unlike systemic arterioles, which dilate in response to hypoxia, pulmonary arterioles undergo vigorous vasoconstriction when alveolar P A O 2 P_A O_2 P A ​ O 2 ​ drops below 70 mmHg 70\text{ mmHg} 70 mmHg . This redistributes pulmonary blood flow away from poorly ventilated alveoli toward well-ventilated regions, preserving V / Q V/Q V / Q matching. Generalized alveolar hypoxia (high altitude, severe COPD) induces global pulmonary vasoconstriction, producing pulmonary arterial hypertension and cor pulmonale.

The Oxygen-Hemoglobin Dissociation Curve

The sigmoidal shape of the curve reflects positive cooperativity among the four heme subunits of adult hemoglobin ( H b A HbA H b A , α 2 β 2 \alpha_2\beta_2 α 2 ​ β 2 ​ ). Oxygen binding to one subunit relaxes the quaternary structure from the low-affinity Tense (T) state to the high-affinity Relaxed (R) state.

Normal P 50 P_{50} P 50 ​ : The partial pressure of oxygen at which hemoglobin is 50% saturated is approximately 26.8 mmHg 26.8\text{ mmHg} 26.8 mmHg . Normal arterial blood ( P a O 2 = 100 mmHg PaO_2 = 100\text{ mmHg} P a O 2 ​ = 100 mmHg ) is 98 % 98\% 98% saturated; mixed venous blood ( P v O 2 = 40 mmHg PvO_2 = 40\text{ mmHg} P v O 2 ​ = 40 mmHg ) is 75 % 75\% 75% saturated.

Shift Direction Physiological Significance Factors Causing Shift

Right Shift (Decreased O 2 O_2 O 2 ​ Affinity, Increased P 50 P_{50} P 50 ​ ) Facilitates oxygen unloading to metabolically active tissues C-A-D-E-T Face Right : Increased C O 2 CO_2 C O 2 ​ ( P a C O 2 > 40 mmHg PaCO_2 > 40\text{ mmHg} P a C O 2 ​ > 40 mmHg ); Increased Acid / Decreased pH (Bohr Effect); Increased 2,3-DPG (2,3-BPG); Exercise; Increased Temperature (hyperthermia)

Left Shift (Increased O 2 O_2 O 2 ​ Affinity, Decreased P 50 P_{50} P 50 ​ ) Impairs oxygen unloading; binds oxygen tightly Decreased C O 2 CO_2 C O 2 ​ / Increased pH (alkalemia); Decreased Temperature (hypothermia); Decreased 2,3-BPG (banked blood); Fetal Hemoglobin ( H b F HbF H b F ); Carbon Monoxide ( C O CO CO poisoning); Methemoglobinemia ( F e 3 + Fe^{3+} F e 3 + )

Bohr Effect : Increased tissue P C O 2 PCO_2 PC O 2 ​ and [ H + ] [H^+] [ H + ] promote carbaminohemoglobin formation and proton binding to globin chains, stabilizing the deoxygenated T-state and releasing oxygen into peripheral capillary beds.

Haldane Effect : Deoxygenation of hemoglobin in peripheral tissues increases its capacity to carry C O 2 CO_2 C O 2 ​ and buffer protons. In the lungs, oxygen binding to hemoglobin displaces C O 2 CO_2 C O 2 ​ and H + H^+ H + , facilitating carbon dioxide exhalation.

Ventilation and dead space

Not all inspired air reaches gas-exchanging alveoli.

Anatomic dead space is about 150 mL in an adult, roughly 2 mL/kg.

Physiologic dead space is anatomic dead space plus alveolar dead space.

Alveolar ventilation = (tidal volume - dead space) x respiratory rate.

Worked example. With a 500-mL tidal volume, 150-mL dead space and 12 breaths per minute, alveolar ventilation is 350 x 12 = 4.2 L/min. Rapid shallow breathing wastes ventilation: 250 mL x 24 gives the same 6 L/min minute ventilation, but only 100 x 24 = 2.4 L/min reaches the alveoli.

Arterial PCO2 is inversely proportional to alveolar ventilation. Halving alveolar ventilation doubles PaCO2.

The five causes of hypoxemia

The alveolar gas equation estimates alveolar PO2 on room air at sea level: P A O 2 = F i O 2 ( P a t m − 47 ) − P a C O 2 0.8 P_AO_2 = F_iO_2(P_{atm} - 47) - \frac{PaCO_2}{0.8} P A ​ O 2 ​ = F i ​ O 2 ​ ( P a t m ​ − 47 ) − 0.8 P a C O 2 ​ ​

which is about 0.21 x 713 - 40/0.8, or roughly 100 mmHg. The normal A-a gradient is under about 10 to 15 mmHg in young adults and widens with age.

  • Cause A-a gradient Response to 100% oxygen
  • Hypoventilation (opioid overdose, neuromuscular weakness) Normal Corrects
  • Low inspired PO2 (altitude) Normal Corrects
  • V/Q mismatch (asthma, COPD, pneumonia) Widened Corrects
  • Shunt (consolidation, atelectasis, intracardiac right-to-left shunt) Widened Corrects poorly
  • Diffusion limitation (interstitial fibrosis, exercise) Widened Corrects
  • Carbon dioxide transport

Form Share of CO2 carried Key point

Bicarbonate About 70% Carbonic anhydrase in red cells forms H2CO3, which splits into H+ and HCO3-. HCO3- leaves the cell in exchange for Cl- (the chloride shift).

Carbamino compounds About 20% to 23% CO2 bound to terminal amino groups of hemoglobin. Deoxyhemoglobin binds more, which is the Haldane effect.

Dissolved CO2 About 7% to 10% CO2 is about 20 times more soluble than O2.

Oxygen content is 1.34 × Hb × S a O 2 + 0.003 × P a O 2 1.34 \times \text{Hb} \times S_aO_2 + 0.003 \times P_aO_2 1.34 × Hb × S a ​ O 2 ​ + 0.003 × P a ​ O 2 ​ (mL O2/dL), so hemoglobin and saturation, not dissolved oxygen, carry almost all of it. In anemia , PaO2 and saturation stay normal but oxygen content falls. In carbon monoxide poisoning , pulse oximetry reads falsely normal while oxygen content and delivery fall, and the curve shifts left.

Control of breathing

Brainstem centers:

The dorsal respiratory group in the medulla sets the inspiratory rhythm.

The ventral group is recruited for forced breathing.

The pneumotaxic center in the upper pons limits inspiration.

The pre-Bötzinger complex generates the basic rhythm.

Central chemoreceptors on the ventral medulla respond to the H+ of cerebrospinal fluid . CO2 crosses the blood-brain barrier and forms H+, so PaCO2 is the dominant minute-to-minute stimulus.

Peripheral chemoreceptors in the carotid bodies (afferents in CN IX) and aortic bodies (CN X) respond mainly to PaO2 below about 60 mmHg , and also to H+ and PCO2.

In chronic CO2 retention , such as severe COPD, CSF bicarbonate compensates and the hypoxic drive matters more. Uncontrolled high-flow oxygen can therefore worsen hypercapnia, mainly through V/Q changes and the Haldane effect. That is why oxygen is titrated to a target saturation of about 88% to 92% in these patients.

Lung stretch receptors (the Hering-Breuer reflex), J receptors and irritant receptors adjust the pattern of breathing.

Exercise, altitude, flying and diving

Exercise: ventilation rises in proportion to metabolism, so arterial PO2, PCO2 and pH stay nearly normal until the anaerobic threshold. Above it, lactic acid drives extra ventilation. Oxygen extraction widens, and the curve shifts right (temperature, CO2, H+).

High altitude and flying:

Lower barometric pressure lowers inspired PO2. Peripheral chemoreceptors trigger hyperventilation , producing respiratory alkalosis , which the kidney compensates by excreting bicarbonate over days.

Acclimatization adds erythropoietin-driven polycythemia, a rise in 2,3-BPG and more capillaries.

Hypoxic pulmonary vasoconstriction can lead to high-altitude pulmonary edema .

Acetazolamide speeds acclimatization by inducing a mild metabolic acidosis.

Commercial cabins are pressurized to an altitude equivalent of about 1,800 to 2,400 m, which can unmask hypoxemia in patients with lung disease.

Diving:

Pressure rises by about 1 atmosphere for every 10 m of seawater. By Boyle's law , gas volume falls as pressure rises, so trapped gas in the ears, sinuses or lungs causes barotrauma .

A breath-holding diver ascending with a closed glottis can rupture alveoli and cause arterial gas embolism.

At depth, more nitrogen dissolves (Henry's law), causing nitrogen narcosis . Rapid ascent lets that nitrogen form bubbles, causing decompression sickness ("the bends"), which is treated with hyperbaric oxygen recompression.

High oxygen partial pressures at depth can cause oxygen toxicity.